Cargando…

Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway

BACKGROUND: Multiple myeloma (MM) is the most common malignant hematological disease in the people worldwide. Glaucocalyxin A (GLA) is a bioactive ent-kauranoid diterpenoid, that is derived from Rabdosia japonica var. GLA has been demonstrated that it had various pharmacological activities, such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mei, Chen, Cailong, Wang, Qian, Jiang, Xiaolu, Tan, Lanlan, Huang, Ying, Zhang, Yan, Zhang, Zubin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684694/ https://www.ncbi.nlm.nih.gov/pubmed/34923957 http://dx.doi.org/10.1186/s12935-021-02375-z

Ejemplares similares

Glaucocalyxin A Ameliorates Myocardial Ischemia-Reperfusion Injury in Mice by Suppression of Microvascular Thrombosis
por: Liu, Xiaohui, et al.
Publicado: (2016)

Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression
por: Wang, Yong, et al.
Publicado: (2020)

Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myeloma
por: Zeng, Zhiyong, et al.
Publicado: (2021)

CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway
por: Yuan, Wanqiong, et al.
Publicado: (2021)

Protective effects of glaucocalyxin A on the airway of asthmatic mice
por: Chen, Si, et al.
Publicado: (2022)

Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p
por: Yang, Xi, et al.
Publicado: (2020)

Ethanol extract of Ligustrum lucidum Ait. leaves suppressed hepatocellular carcinoma in vitro and in vivo
por: Tian, Guoyan, et al.
Publicado: (2019)

Rcl1 suppresses tumor progression of hepatocellular carcinoma: a comprehensive analysis of bioinformatics and in vitro experiments
por: Jiaze, Yu, et al.
Publicado: (2022)

Knockdown of MCM8 inhibits development and progression of bladder cancer in vitro and in vivo
por: Zhu, Wei, et al.
Publicado: (2021)

A novel strategy for the characterization of glaucocalyxin A metabolites in vivo and in vitro by UHPLC-Q-TOF-MS based on DDA and DIA data acquisitions
por: Sun, Wenjing, et al.
Publicado: (2020)

Circular RNA circCSPP1 knockdown attenuates doxorubicin resistance and suppresses tumor progression of colorectal cancer via miR-944/FZD7 axis
por: Xi, Lanlan, et al.
Publicado: (2021)

Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress
por: Zhang, Tingting, et al.
Publicado: (2022)

Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination
por: Li, Zhenhai, et al.
Publicado: (2020)

Identification of key biomarkers associated with cell adhesion in multiple myeloma by integrated bioinformatics analysis
por: Peng, Yue, et al.
Publicado: (2020)

Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma
por: Fu, Rong, et al.
Publicado: (2014)

Knockdown of lncRNA PVT1 inhibits prostate cancer progression in vitro and in vivo by the suppression of KIF23 through stimulating miR-15a-5p
por: Wu, Huijuan, et al.
Publicado: (2020)

Circ_0007841 promotes the progression of multiple myeloma through targeting miR-338-3p/BRD4 signaling cascade
por: Wang, Yan, et al.
Publicado: (2020)

A novel chalcone derivative suppresses melanoma cell growth through targeting Fyn/Stat3 pathway
por: Tang, Ling, et al.
Publicado: (2020)

NF-kB-dependent activation of STAT3 by H. pylori is suppressed by TFF1
por: Soutto, Mohammed, et al.
Publicado: (2021)

Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage
por: Sun, Runjie, et al.
Publicado: (2021)

Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes
por: Went, Molly, et al.
Publicado: (2019)

Glaucocalyxin A alleviates lipopolysaccharide-induced inflammation and apoptosis in pulmonary microvascular endothelial cells and permeability injury by inhibiting STAT3 signaling
por: Cao, Jianwei, et al.
Publicado: (2022)

TET2 suppresses nasopharyngeal carcinoma progression by inhibiting glycolysis metabolism
por: Zhang, Xixia, et al.
Publicado: (2020)

Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
por: Wong, Kwan Yeung, et al.
Publicado: (2013)

SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway
por: Liu, Zelin, et al.
Publicado: (2022)

Attenuated expression of SNF5 facilitates progression of bladder cancer via STAT3 activation
por: Ding, Hua, et al.
Publicado: (2021)

Glucosamine suppresses proliferation of human prostate carcinoma DU145 cells through inhibition of STAT3 signaling
por: Chesnokov, Viktor, et al.
Publicado: (2009)

Elevation of miR-302b prevents multiple myeloma cell growth and bone destruction by blocking DKK1 secretion
por: Wu, Zheyu, et al.
Publicado: (2021)

Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo
por: Bi, Guoshu, et al.
Publicado: (2021)

Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo
por: Wang, Lei, et al.
Publicado: (2014)

Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma
por: Liu, Shuli, et al.
Publicado: (2017)

LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway
por: Yu, Chuigong, et al.
Publicado: (2022)

miR-335-5p suppresses gastric cancer progression by targeting MAPK10
por: Gao, Yi, et al.
Publicado: (2021)

Glaucocalyxin A Inhibits Platelet Activation and Thrombus Formation Preferentially via GPVI Signaling Pathway
por: Li, Wei, et al.
Publicado: (2013)

CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3
por: Mei, Mei, et al.
Publicado: (2021)

Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017
por: Yin, Xuejiao, et al.
Publicado: (2018)

Preparation, optimization of the inclusion complex of glaucocalyxin A with sulfobutylether-β-cyclodextrin and antitumor study
por: Ren, Lili, et al.
Publicado: (2019)

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3
por: Zhu, Shicong, et al.
Publicado: (2015)

Ku86 exists as both a full-length and a protease-sensitive natural variant in multiple myeloma cells
por: Gullo, Charles A, et al.
Publicado: (2008)

Blocking circ-SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR-338-3p and regulating LIN28B
por: Qiu, Feng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ce95up3cmp5g6ddfcn1h9v2h0e